M T Roe

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion
    M T Roe
    Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    J Am Coll Cardiol 37:9-18. 2001
  2. ncbi Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial
    M T Roe
    Duke Clinical Research Institute, Durham, NC, USA
    Circulation 102:1101-6. 2000
  3. ncbi Treatment strategies for microvascular dysfunction following acute myocardial infarction
    M T Roe
    Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    Curr Cardiol Rep 2:405-10. 2000
  4. ncbi Clinical information determines the impact of transesophageal echocardiography on the diagnosis of infective endocarditis by the duke criteria
    M T Roe
    Department of Internal Medicine, Duke University Medical Center, Durham, NC 27715, USA
    Am Heart J 139:945-51. 2000
  5. ncbi Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes
    M T Roe
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Eur Heart J 25:313-21. 2004
  6. ncbi Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction
    M T Roe
    Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    Am J Cardiol 88:170-3, A6. 2001
  7. ncbi Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy
    J G Peterson
    Department of Cardiology, The Cleveland Clinic Foundation, Ohio 44195, USA
    Am J Cardiol 87:532-6. 2001
  8. ncbi Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study
    H D Aronow
    Department of Cardiology, Cleveland Clinic Foundation, OH 44195, USA
    Lancet 357:1063-8. 2001
  9. ncbi Clinical outcome of a cohort of patients eligible for therapeutic angiogenesis or transmyocardial revascularization
    D Mukherjee
    Department of Cardiology, University of Michigan, USA
    Am Heart J 142:72-4. 2001

Detail Information

Publications9

  1. ncbi Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion
    M T Roe
    Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    J Am Coll Cardiol 37:9-18. 2001
    ..Thus, as the reperfusion era moves into the next millennium, the open-artery hypothesis is expected to shift downstream and guide efforts to further improve myocardial salvage and clinical outcomes after acute MI...
  2. ncbi Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial
    M T Roe
    Duke Clinical Research Institute, Durham, NC, USA
    Circulation 102:1101-6. 2000
    ..A proportion of patients who present with suspected acute coronary syndrome (ACS) are found to have insignificant coronary artery disease (CAD) during coronary angiography, but these patients have not been well characterized...
  3. ncbi Treatment strategies for microvascular dysfunction following acute myocardial infarction
    M T Roe
    Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    Curr Cardiol Rep 2:405-10. 2000
    ..Therefore, shifting the focus of reperfusion therapy to the microcirculation offers the potential to further improve myocardial salvage and clinical outcomes following acute myocardial infarction...
  4. ncbi Clinical information determines the impact of transesophageal echocardiography on the diagnosis of infective endocarditis by the duke criteria
    M T Roe
    Department of Internal Medicine, Duke University Medical Center, Durham, NC 27715, USA
    Am Heart J 139:945-51. 2000
    ....
  5. ncbi Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes
    M T Roe
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Eur Heart J 25:313-21. 2004
    ..To study the relationship between outcomes and peak creatine kinase (CK)-MB levels after percutaneous coronary intervention (PCI) in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS)...
  6. ncbi Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction
    M T Roe
    Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    Am J Cardiol 88:170-3, A6. 2001
    ..Patients who underwent multivessel coronary intervention had a higher risk of adverse clinical outcomes through 6 months compared with matched controls in whom coronary intervention was limited to the infarct-related artery...
  7. ncbi Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy
    J G Peterson
    Department of Cardiology, The Cleveland Clinic Foundation, Ohio 44195, USA
    Am J Cardiol 87:532-6. 2001
    ..31, 95% CI 0.10 to 0.93, p = 0.04). Thus, the apparent positive impact of heparin on the benefits of eptifibatide therapy was largely due to confounding and bias...
  8. ncbi Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study
    H D Aronow
    Department of Cardiology, Cleveland Clinic Foundation, OH 44195, USA
    Lancet 357:1063-8. 2001
    ..67 [0.48-0.95], p=0.023). INTERPRETATION: Prescription of a lipid-lowering drug at hospital discharge was independently associated with reduced short-term mortality among patients after an acute coronary syndrome...
  9. ncbi Clinical outcome of a cohort of patients eligible for therapeutic angiogenesis or transmyocardial revascularization
    D Mukherjee
    Department of Cardiology, University of Michigan, USA
    Am Heart J 142:72-4. 2001
    ..5% rate of myocardial infarction (15 of 59), and a mortality rate of 16.9% (10 of 59). CONCLUSIONS: The prognosis of many patients eligible for newer methods of revascularization on maximal medical therapy is poor...